Mode
Text Size
Log in / Sign up

Protein-energy wasting prevalence reaches 47.0% among patients with chronic kidney disease in AfricaNearly half of African kidney disease patients suffer from malnutrition

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the high prevalence of protein-energy wasting (47.0%) in African patients with chronic kidney disease.

This meta-analysis synthesized data from 25 studies involving 2822 participants to determine the prevalence of protein-energy wasting (PEW) among patients with chronic kidney disease (CKD) in Africa. The study highlights a significant burden of malnutrition in this population, with an overall pooled prevalence of PEW at 47.0% (95% confidence interval: 39.0%-56.0%).

Specific findings indicate that hemodialysis patients have a higher prevalence of PEW at 52.0% compared to 34.0% in non-dialysis CKD patients. The prevalence of PEW varied significantly depending on the diagnostic criteria used: 32.0% using International Society of Renal Nutrition and Metabolism criteria, 49.0% using Malnutrition Inflammatory Score, 42.0% using Subjective Global Assessment, and 76.0% using a Subjective Global Assessment adaptation.

The authors note high heterogeneity in the results (I2 = 95.5%). The findings suggest that PEW is highly prevalent among African patients with CKD, indicating a need for region-specific guidelines and multidisciplinary nutritional interventions. Clinical application is limited by the high heterogeneity of the included data.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the nutritional status of patients with chronic kidney disease specifically within the African region. While prior coverage has addressed other aspects of CKD management, such as the use of intranasal desmopressin to reduce bleeding risk and the impact of the cGAS-STING pathway on inflammation, this study provides specific data on the prevalence of protein-energy wasting (PEW) in African populations.

Living with chronic kidney disease is hard enough, but many patients in Africa face an additional hurdle: protein-energy wasting. This condition, often called PEW, happens when the body loses muscle and weight due to the demands of kidney failure. It can make it much harder for patients to maintain their strength and overall health.

Data from 25 different studies involving over 2,800 people shows that about 47% of these patients suffer from this type of malnutrition. The numbers are even higher for those on hemodialysis, where the rate of malnutrition jumps to 52%. While different ways of measuring the condition give slightly different results, the core finding remains clear: malnutrition is a major issue for those with kidney disease in the region.

Because the data comes from many different studies, there is a lot of variation in the results. However, the high rate of malnutrition suggests that more specific nutritional care and local guidelines are needed to help these patients stay healthy. Talk to a doctor or a specialist to understand how these findings might affect specific care plans.

What this means for you:
Nearly half of patients with chronic kidney disease in Africa suffer from significant protein-energy wasting.

Common questions

What is protein-energy wasting?

Protein-energy wasting, or PEW, is a condition where a person loses muscle and weight because their body cannot keep up with the demands of their illness. In this study, it was found that 47% of patients with chronic kidney disease in Africa experienced this type of malnutrition.

Is it more common in patients on dialysis?

Yes, the data shows that the prevalence of protein-energy wasting is higher in patients undergoing hemodialysis. Specifically, 52% of those on hemodialysis were found to have this condition, compared to 34% of patients who were not on dialysis.

How common is this condition in the region?

The study looked at 2,822 participants across 25 different studies in Africa. It found that the overall prevalence of protein-energy wasting among these patients was 47%.

Study Details

Study typeMeta analysis
Sample sizen = 25
EvidenceLevel 1
Follow-up62.4 mo
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Protein-energy wasting (PEW) is a frequent and prognostically adverse complication of chronic kidney disease (CKD). Despite its clinical importance, African populations have been underrepresented in prior systematic reviews. This study aimed to estimate the pooled prevalence of PEW among patients with CKD in Africa. METHODS: PubMed, AJOL, and EMBASE were systematically searched for relevant studies published between 1980 and 2025. Meta-analytic techniques were used to estimate the pooled prevalence of PEW among African CKD populations. The study protocol was registered on PROSPERO (CRD420251032894). RESULTS: Twenty-five articles comprising 2822 participants across 14 African countries met the inclusion criteria. The mean age of the participants was 49.7 ± 5.2 years. Thirteen studies (52.0%) were from North Africa, 19 studies (76.0%) had high methodological quality, and 17 studies (68.0%) used Subjective Global Assessment (SGA) for PEW assessment. The overall pooled prevalence of PEW among patients with CKD was 47.0% (95% confidence interval: 39.0%-56.0%; n = 25 studies; I2 = 95.5%, P < .001). The prevalence of PEW was significantly higher in the haemodialysis patients compared with non-dialysis CKD patients (52.0% vs 34.0%; P < .001). The pooled prevalence of PEW in studies that used the International Society of Renal Nutrition and Metabolism criteria was 32.0%; Malnutrition Inflammatory Score was 49.0%, SGA was 42.0%; and SGA adaptation was 76.0%. There was a significant difference in the pooled PEW prevalence across diagnostic criteria (P < .001) and African regions (P < .001). CONCLUSION: PEW is highly prevalent among African patients with CKD. Region-specific guidelines and multidisciplinary nutritional interventions are urgently needed to address this burden.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.